Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.24.3
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2024
Net Loss per Common Share  
Schedule of Diluted Weighted Average Shares Outstanding

​

​

​

​

​

​

​

    

​

​

​

September 30, 

​

​

2024

    

2023

Warrants to purchase Common Stock

 

14,499,535

 

127,296

Options to purchase Common Stock

 

558,896

 

160,233

Unvested Restricted Stock

 

1,628,082

 

1,338,750

Unvested Restricted Stock Units

 

166,160

 

106,708

Total

 

16,852,673

 

1,732,987

​